What is it about?

Review article of the effect of all classes of antidabetic drugs, including incretin based therapy, and SGLT-2 inhibitors on heart failure

Featured Image

Read the Original

This page is a summary of: Vércukorcsökkentő gyógyszerek biztonságossága szívelégtelenségben, Orvosi Hetilap, February 2017, Akademiai Kiado,
DOI: 10.1556/650.2017.30652.
You can read the full text:

Read

Contributors

The following have contributed to this page